ArticleThe Biochemical journal2025
Cyclophilin D reduces Ca2+ sequestration by complement 1q binding protein.
Article in The Biochemical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Complement 1q binding protein (C1qBP) and cyclophilin D (CypD) are mitochondrial matrix proteins; C1qBP has been implicated in many cellular processes, including the regulation of oxidative phosphorylation, and CypD is widely associated with the regulation of mitochondrial permeability transition pore (mPTP) opening. In this study, C1qBP and CypD were shown, in vitro, to form a stable protein-protein complex. CypD-C1qBP interaction was disrupted by cyclosporin A and compromised by mutations of the CypD active site residues R55 and R82. AlphaFold protein modelling revealed that the large negatively charged surface of C1qBP binds to the positive surface of CypD. This electrostatically driven interaction was confirmed by the pH dependence of the protein-protein interaction, with lower affinities observed at higher pH values. C1qBP was shown to undergo conformational changes when bound to Ca2+ in vitro, conferring multiple Ca2+ interaction sites in a multi-phase process, thereby indicating that C1qBP may act as a Ca2+ sequester. In contrast, CypD binding to C1qBP diminished the Ca2+-induced conformational changes in C1qBP, lowering its Ca2+-binding capacity. Our findings suggest that C1qBP functions as a mitochondrial Ca2+ chelator, with its efficiency reduced by CypD, this most likely due to CypD and Ca2+ both competing for the same negative surface of C1qBP. The parallels between the features of CypD-C1qBP interaction and the regulation of Ca2+-dependent mPTP opening by CypD highlight a possible functional role of CypD which has so far been elusive.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.